| Name | (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-[4-fluoro-5-propan-2-yl-2-(trideuteriomethoxy)phenyl]-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one |
|---|---|
| Synonyms |
MK 0859-d3
Anacetrapib-d3 |
| Description |
|---|
| Molecular Formula | C30H22D3F10NO3 |
|---|---|
| Molecular Weight | 640.52700 |
| Exact Mass | 640.18600 |
| PSA | 38.77000 |
| LogP | 9.70100 |
|
~58%
1061715-90-9 |
| Literature: CONCERT PHARMCEUTICALS, INC. Patent: US2008/242711 A1, 2008 ; Location in patent: Page/Page column 15-16 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |